FibroBiologics, Inc. Common Stock Stock Analysis & AI Score
FibroBiologics, Inc. Common Stock (FBLG) has an ST Score of 29.9 (C-), driven by its Forecast (B+) and held back by its Profitability (F). Analysts rate it Buy with a $180.00 price target (+18652.0% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
AI Daily Briefing
Analysis by AIFBLG Stock Price History
FBLG Technical Indicators
FMPEarnings Surprises
Analyst Forecast
Revenue Mix
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Analyst Price Target
ESG Score
FBLG Latest Stock News
ST Score
FibroBiologics, Inc. Common Stock (FBLG) has an ST Score of 29.9 (C-), driven by its Forecast (B+) and held back by its Profitability (F). Analysts rate it Buy with a $180.00 price target (+18652.0% upside).
- Strongest
- ForecastB+
- Weakest
- ProfitabilityF
All factor grades
- ForecastB+
- MomentumC+
- ValuationC-
- GrowthC-
- Financial StrengthD-
- ProfitabilityF
- Piotroski2/9
Press Releases
Company Contact Details
FBLG stock: frequently asked questions
What is FBLG's ST Score?
FibroBiologics, Inc. Common Stock (FBLG) has an ST Score of 29.9 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is FBLG a buy, hold, or sell?
Analysts rate FBLG a Buy, with a price target of $180.00 (+18652.0% vs the current price). Our ST Score grades it C- (29.9/100). The ST Score is a data-driven signal, not a recommendation.
What are FBLG's factor grades?
Valuation C-, Profitability F, Financial Strength D-, Momentum C+, Growth C-, Forecast B+.
What is FBLG's valuation grade?
FibroBiologics, Inc. Common Stock (FBLG) earns a valuation grade of C-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is FBLG's growth grade?
FibroBiologics, Inc. Common Stock (FBLG) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is FBLG's profitability grade?
FibroBiologics, Inc. Common Stock (FBLG) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is FBLG's financial strength grade?
FibroBiologics, Inc. Common Stock (FBLG) earns a financial strength grade of D-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for FBLG?
The average analyst price target for FibroBiologics, Inc. Common Stock (FBLG) is $180.00 from 4 analysts, which is +18652.0% versus the recent price of $0.96.
What is FBLG's Piotroski score?
FibroBiologics, Inc. Common Stock (FBLG) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.